Physicians' Academy for Cardiovascular Education

Biology and validation of PCSK9 as a novel target to lower LDL-C

Slides (presentation) - Sep. 9, 2014

Presentation by prof. John Kastelein, MD, Amsterdam, at PACE symposium 'Innovations in lipid management: Evolving insights and implications from PCSK9 research' on August 30, 2014 at ESC in Barcelona

Download Biology and validation of PCSK9 as a novel target to loer LDL-c Dr Kastelein.pdf
 

To view slides, click on images